PROFUSA, INC. Debt Instrument, Face Amount
PROFUSA, INC. (PFSA) had Debt Instrument, Face Amount of $200.00 thousand as of 2021-11-05, per its 10-K filed 2024-02-26.
Discontinued › Notes
us-gaap:DebtInstrumentFaceAmount · last filed 2024-02-26
- 2021-11-05: Debt Instrument, Face Amount $200.00K.
- 2021-04-19: Debt Instrument, Face Amount $150.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2021-11-05 | $200.00K 10-K · filed 2024-02-26 |
| 2021-04-19 | $150.00K 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |